Cocrystal Pharma, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 9 →Insiders1 insider bought $300,525 in 11 open-market buys. No sales.→HoldersVanguard 2.6%Renaissance Technologies 1.3%Two Sigma Investments 1.3%→Financing →
From the filings
Figures
- Net income
- −$9.9Mlast 12 months
- Operating cash flow
- −$7.6Mlast 12 months
- Cash and equivalents
- $7.0Mat the last balance sheet
- Shares outstanding
- 13.8M shareson issue